Bernard A, Rigault C, Mazue F, Le Borgne F, Demarquoy J
Recombinant DNA technology offers a solution to the limitations of chemical synthesis by enabling high-yield, low-cost peptide production
6 Alternatively, some patients may be prescribed sulfonylureas or thiazolidiniones to improve insulin secretion, but both of these treatment options are associated with an elevated risk of heart failure making them unsuitable for use in patients with cardiovascular disease
Medical References Wilding JPH, Batterham RL, Calanna S, et al
(2) ATP depletion under hypoxia generates xanthine, converting xanthine dehydrogenase to xanthine oxidase